ZION Stock Analysis: Zions Bancorporation | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 9.616m USD | 12M Return: 27% | US9897011071 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 95.0M
EPS Trend: 95.4%
Qual. Beats: 6
Rev. Trend: 79.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Zions Bancorporation (ZION) is a regional U.S. bank holding company headquartered in Salt Lake City, Utah, founded in 1873. It operates primarily across 11 western states through seven distinct bank charters, including Zions Bank, California Bank & Trust, Amegy Bank, and National Bank of Arizona. The company provides a full suite of commercial banking, small business lending, retail banking, wealth management, and capital markets/investment banking services. Its multi-brand structure reflects a growth strategy built largely through the acquisition and integration of regional banks, a common approach among U.S. regional banks seeking scale and geographic diversification while maintaining local market identity. The company rebranded from ZB, National Association to its current name in September 2018.
- Net interest margin expansion lifts earnings amid elevated rates
- Commercial real estate loan losses threaten credit quality
- Deposit costs pressure margins as competition for funding intensifies
| Net Income: 1.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.66 > 1.0 |
| NWC/Revenue: -1.08k% < 20% (prev -1.33k%; Δ 247.6% < -1%) |
| CFO/TA 0.03 > 3% & CFO 2.65b > Net Income 1.21b |
| Net Debt (-19.6b) to EBITDA (1.67b): -11.72 < 3 |
| Current Ratio: 0.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (145.1m) vs 12m ago -1.38% < -2% |
| Gross Margin: 73.04% > 18% (prev 64.81%; Δ 8.23% > 0.5%) |
| Asset Turnover: 5.75% > 50% (prev 5.59%; Δ 0.16% > 0%) |
| Interest Coverage Ratio: 1.11 > 6 (EBIT TTM 1.55b / Interest Expense TTM 1.40b) |
| A: -0.62 (Total Current Assets 22.9b - Total Current Liabilities 78.8b) / Total Assets 90.9b |
| B: 0.09 (Retained Earnings 8.07b / Total Assets 90.9b) |
| C: 0.02 (EBIT TTM 1.55b / Avg Total Assets 89.7b) |
| D: 0.09 (Book Value of Equity 7.68b / Total Liabilities 83.2b) |
| Altman-Z'' = -3.53 = D |
As of November 20, 2026, the stock is trading at USD 62.24 with a total of 1,512,463 shares traded. Over the past week, the price has changed by -5.63%, over one month by -0.71%, over three months by -8.20% and over the past year by +27.01%.
Current recommended Stop Loss: 60.10 (which is 3.4% or 1.5 ATR below the current price).
Zions Bancorporation has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold ZION.
- StrongBuy: 8
- Buy: 0
- Hold: 11
- Sell: 2
- StrongSell: 2
| Analysts Target Price | 72.6 | 16.7% |
P/E Trailing = 8.1399
P/E Forward = 9.5511
P/S = 2.5547
P/B = 1.262
P/EG = 3.5373
Revenue TTM = 5.16b USD
EBIT TTM = 1.55b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 2.41b USD (from longTermDebt, last quarter)
Short Term Debt = 843.0m USD (from shortTermDebt, last quarter)
Debt = 3.26b USD (from shortLongTermDebtTotal, last quarter) + Leases 3.00m
Net Debt = -19.6b USD (calculated: Debt 3.26b - CCE 22.8b)
Enterprise Value = 9.62b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.11 (Ebit TTM 1.55b / Interest Expense TTM 1.40b)
EV/FCF = 3.85x (Enterprise Value 9.62b / FCF TTM 2.50b)
FCF Yield = 25.95% (FCF TTM 2.50b / Enterprise Value 9.62b)
FCF Margin = 48.39% (FCF TTM 2.50b / Revenue TTM 5.16b)
Net Margin = 23.51% (Net Income TTM 1.21b / Revenue TTM 5.16b)
Gross Margin = 73.04% ((Revenue TTM 5.16b - Cost of Revenue TTM 1.39b) / Revenue TTM)
Gross Margin QoQ = 71.52% (prev 76.67%)
Tobins Q-Ratio = 0.11 (Enterprise Value 9.62b / Total Assets 90.9b)
Interest Expense / Debt = 42.80% (Interest Expense 1.40b / Debt 3.26b)
Taxrate = 21.91% (340.0m / 1.55b)
NOPAT = 1.21b (EBIT 1.55b * (1 - 21.91%))
Current Ratio = 0.29 (Total Current Assets 22.9b / Total Current Liabilities 78.8b)
Debt / Equity = 0.42 (Debt 3.26b / totalStockholderEquity, last quarter 7.68b)
Debt / EBITDA = -11.72 (Net Debt -19.6b / EBITDA 1.67b)
Debt / FCF = -7.84 (Net Debt -19.6b / FCF TTM 2.50b)
Total Stockholder Equity = 7.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.35% (Net Income 1.21b / Total Assets 90.9b)
RoE = 16.25% (Net Income TTM 1.21b / Total Stockholder Equity 7.46b)
RoCE = 15.72% (EBIT 1.55b / Capital Employed (Equity 7.46b + L.T.Debt 2.41b))
RoIC = 9.53% (NOPAT 1.21b / Invested Capital 12.7b)
WACC = 15.02% (E(9.62b)/V(12.9b) * Re(8.78%) + D(3.26b)/V(12.9b) * Rd(42.80%) * (1-Tc(0.22)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -70.84 | Cagr: -0.62%
[DCF] Terminal Value 59.43% ; FCFF base≈1.88b ; Y1≈2.16b ; Y5≈3.17b
[DCF] Fair Price = 284.7 (EV 21.7b - Net Debt -19.6b = Equity 41.3b / Shares 144.9m; r=15.02% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.35 | EPS CAGR: 15.14% | SUE: 1.50 | # QB: 6
Revenue Correlation: 79.28 | Revenue CAGR: 3.85% | SUE: 0.58 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.53 | Chg30d=+0.07% | Revisions=-22% | Analysts=9
EPS current Year (2026-12-31): EPS=6.74 | Chg30d=+2.56% | Revisions=+81% | GrowthEPS=+15.7% | GrowthRev=+5.6%
EPS next Year (2027-12-31): EPS=6.93 | Chg30d=+1.88% | Revisions=+47% | GrowthEPS=+2.9% | GrowthRev=+3.2%
[Analyst] Revisions Ratio: +53% (up=26, down=7)